BEIJING, June 12 /Xinhua-PRNewswire-FirstCall/ -- China Medical
Technologies, Inc. (the "Company") (Nasdaq: CMED), a leading China-based
medical device company that develops, manufactures and markets advanced in-
vitro diagnostic products and high intensity focused ultrasound tumor
therapy system, today announced its unaudited financial results for the
fourth quarter ("4Q FY2007") and the full year of the fiscal year ended
March 31, 2008 ("FY2007").
4Q FY2007 Highlights
-- Revenues increased by 74.3% year-over-year to RMB284.2 million
(US$40.5 million).
-- Non-GAAP adjusted net income, as defined below, increased by 45.5%
year-over-year to RMB133.6 million (US$19.1 million).
-- Non-GAAP adjusted diluted earnings per ADS*, as defined below,
increased by 38.3% year-over-year to RMB4.66 (US$0.66).
FY2007 Highlights
-- Revenues increased by 67.4% year-over-year to RMB915.7 million
(US$130.6 million) exceeding the high end of our targeted range of
RMB885 million.
-- Non-GAAP adjusted net income, as defined below, increased by 39.4%
year-over-year to RMB432.1 million (US$61.6 million) exceeding the
high end of our targeted range of RMB420 million.
-- Non-GAAP adjusted diluted earnings per ADS*, as defined below, were
RMB15.44 (US$2.20) exceeding the high end of our targeted range of
RMB15.10.
-- Cash dividend of US$0.5 per ADS* was declared which increased by
25.0% as compared to cash dividend of US$0.4 per ADS last year.
* One American Depositary Share ("ADS") = 10 ordinary shares
See "Non-GAAP Measure Disclosures" below, where the impact of certain
items on reported results is
'/>"/>
| SOURCE China Medical Technologies, Inc. Copyright©2008 PR Newswire. All rights reserved |